Voloridge Investment Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $3.47M | Sell |
|
|||||
|
2023
Q1 | $6.86M | Buy |
|
|||||
|
2022
Q4 | $5.76M | Buy |
|
|||||
|
2022
Q3 | $6.13M | Sell |
|
|||||
|
2022
Q2 | $10.1M | Buy |
|
|||||
|
2022
Q1 | $12M | Buy |
|
|||||
|
2021
Q4 | $8.3M | Buy |
|
|||||
|
2021
Q3 | $9.47M | Sell |
|
|||||
|
2021
Q2 | $12.4M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $9.07M | Buy |
|
|||||
|
2020
Q2 | $373K | Sell |
|
|||||
|
2020
Q1 | $612K | Buy |
|
|||||
|
2019
Q4 | $358K | Sell |
|
|||||
|
2019
Q3 | $1.74M | Buy |
|
|||||
|
2019
Q2 | $766K | Buy |
|